
About Crenza Pharmaceuticals
Crenza Pharmaceuticals is a Healthcare company based in Hyderabad (India) founded in 2017. It offers contract-based development and manufacturing of pharmaceutical injectables and ophthalmic drugs. It operates on a B2B model. The company has 31 employees. Its Indian entity Crenza Pharmaceuticals Private Limited reported revenue of βΉ5.97 Cr. Crenza Pharmaceuticals offers products and services including Contract Manufacturing, Contract Packaging, Analytical Services, Stability Studies, and Formulation Development. Its focus areas include Pharmaceuticals, Drug Development and Injectables and Ophthalmics. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.
Company details
Crenza Pharmaceuticals Pvt. Ltd. is a contract research organization based in Hyderabad, India, specializing in the development and manufacturing of complex injectable and ophthalmic drugs. They provide services like formulation development, analytical studies, stability testing, and packaging through collaborative client relationships. Using RD expertise and advanced technologies, they deliver high-quality solutions at competitive prices for global markets, ensuring regulatory compliance and efficient commercialization.
- Headquarters Hyderabad, India
- Employees 31
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website crenzapharma.com
- Legal Name Crenza Pharmaceuticals Private Limited
- Date of Incorporation 22 May, 2017
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹5.97 Cr
FY 2025 · +3% YoY
- Net Profit₹25.8 Lakh
FY 2025 · 4% margin
- EBITDA₹1.14 Cr
FY 2025 · 19% margin
- Employee Count31
Associated legal entities of Crenza Pharmaceuticals
Crenza Pharmaceuticals operates through Crenza Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Crenza Pharmaceuticals Private Limited CIN U24304TG2017PTC117228 | Active | 22 May 2017 | Hyderabad, Telangana | ₹6.0 Cr | 31 | 2 | View details |
Products & Services of Crenza Pharmaceuticals
Crenza Pharmaceuticals offers a comprehensive portfolio of products and services, including Contract Manufacturing, Contract Packaging, Analytical Services, Stability Studies, and Formulation Development.
Manufactures pharmaceutical injectables and ophthalmic drugs for clients.
Provides packaging for pharmaceutical products to meet standards.
Conducts testing for active ingredients and excipients in drugs.
Performs stability testing for pharmaceutical formulations.
Develops formulations for injectables and ophthalmic drugs.
Board of directors of Crenza Pharmaceuticals Private Limited (Crenza Pharmaceuticals)
Crenza Pharmaceuticals Private Limited is the primary company behind Crenza Pharmaceuticals. The board of Crenza Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Sandhya Pittala, appointed in 2017. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sandhya Pittala DIN 07812468 | Whole-time director | 22 May 2017 | 9 yrs 5 mo | Crenza Pharmaceuticals Private Limited |
| Satyanarayana Pittala DIN 08467067 | Director | 30 May 2019 | 7 yrs 5 mo | Crenza Pharmaceuticals Private Limited |
Financials of Crenza Pharmaceuticals
Figures of Crenza Pharmaceuticals Private Limited, the primary company behind Crenza Pharmaceuticals, for FY 2025. Revenue was ₹5.97 Cr (+3% year on year). Net profit was ₹25.8 Lakh (4% margin). EBITDA was ₹1.14 Cr (19% margin). Revenue has grown at a compounded annual rate of +12% over three years and +13% over five years.
- ₹5.97 CrRevenue · FY 2025 · +3% YoY
- ₹25.8 LakhNet profit · 4% margin
- ₹1.14 CrEBITDA · 19% margin
- ₹50,000Paid-up capital
- 31Employees (provident fund records)
- +12%Revenue CAGR, 3 years
- +13%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Crenza Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Crenza Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Crenza Pharmaceuticals
Crenza Pharmaceuticals has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | Company offering a suite of R&D and manufacturing services for small molecules and generics | |||
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. |
Detailed similar companies of Crenza Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Crenza Pharmaceuticals
Crenza Pharmaceuticals was founded in 2017.
Crenza Pharmaceuticals is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Crenza Pharmaceuticals has 31 employees.
The primary company behind Crenza Pharmaceuticals, Crenza Pharmaceuticals Private Limited, reported revenue of βΉ5.97 Cr for FY 2025, up 3% year on year.
Crenza Pharmaceuticals Pvt. Ltd. is a contract research organization based in Hyderabad, India, specializing in the development and manufacturing of complex injectable and ophthalmic drugs. They provide services like formulation development, analytical studies, stability testing, and packaging through collaborative client relationships. Using RD expertise and advanced technologies, they deliver high-quality solutions at competitive prices for global markets, ensuring regulatory compliance and efficient commercialization.
Crenza Pharmaceuticals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Crenza Pharmaceuticals offers Contract Manufacturing, Contract Packaging, Analytical Services, Stability Studies, and Formulation Development.
Crenza Pharmaceuticals operates through Crenza Pharmaceuticals Private Limited.
The legal entities of Crenza Pharmaceuticals currently have 2 directors, including Sandhya Pittala, Satyanarayana Pittala.